Page 29 - A9Rc19d2z_zddyc4_fc0.tmp

Early Detection of Neovascular Age-related macular Male synthetic sling versus Artificial urinary Sphincter
degeneration (EDNA) Trial for men with urodynamic stress incontinence
Investigators: Chakravarthy, U., Hogg, R. (Queen’s University after prostate surgery: Evaluation by Randomised trial
Belfast); Ramsay, C., Banister, K., Cook, J., Azuara-Blanco, (MASTER)
A. (Health Services Research Unit, (HSRU), University of Investigators: Abrams, P. (North Bristol NHS Trust); Drake,
Aberdeen); Scotland, G. (HERU/HSRU); Sivaprasad, S. M. (University of Bristol); Glazener, C., Norrie, J., Ramsay,
(Moorfields Eye Hospital NHS Foundation Trust); Heimann, H. C., Boachie, C., McCormack, K., McPherson, G., McDonald,
(Royal Liverpool & Broadgreen University Hospitals NHS Trust). A. (Health Services Research Unit, (HSRU), University of
Source of Funding: National Institute for Health Research Aberdeen); Pickard, R. (University of Newcastle upon Tyne);
(NIHR) Health Technology Assessment (HTA) Programme and Kilonzo, M. (HERU); Cotterill, N. (University of Bristol).
Chief Scientist Office (CSO) CORE. Source of Funding: National Institute for Health Research,
Health Technology Assessment (HTA) Programme and
*Effects and safety of testosterone in men with low University of Aberdeen.
testosterone levels: an evidence synthesis and economic
evaluation (Testosterone Effects and Safety) Consortium Oral iron, Intravenous iron or discontinuation of therapy
(TESTES) for older adults with treatment-unresponsive iron
Investigators: Jayasena, C. (Imperial College of Science, deficiency anaemia – a pilot randomised controlled trial
Technology and Medicine); Hernández, R. (HERU); Dhilo, W. Investigators: Myint, P. (Other Applied Health Sciences,
(Imperial College London); Wu, F. (University of Manchester); University of Aberdeen); McNamee, P. (HERU); Witham,
Bhattacharya, S., Gillies, K., Brazzelli, M., Aucott, L. (University M., Hands, K. (Ninewells Hospital Dundee); Lee, A. (Medical
of Aberdeen); Quinton, R. (Freeman Hospital); Oliver, N. Statistics, University of Aberdeen).
(Imperial College London). Source of Funding: The Scottish Government – Chief
Source of Funding: National Institute for Health Research Scientist Office (CSO) and University of Aberdeen.
(NIHR), Health Technology Assessment (HTA) Programme and
University of Aberdeen. A randomised controlled trial comparing the clinical
effectiveness and cost-effectiveness of laparoscopic
External validity of DCEs: a case study of dental care (PhD) cholecystectomy compared with observation/
Investigators: Boyers, D. (PhD Student), Pol, M. van der, conservative management for preventing recurrent
Watson, V. (HERU). symptoms and complications in adults with
Source of Funding: Chief Scientist Office (CSO) CORE and uncomplicated symptomatic gallstones (C-Gall)
University of Aberdeen. Investigators: Ahmed, I. (NHS Grampian); Ramsay, C., Norrie,
J., Gillies, K., Avenell, A., Brazzelli, M. (Health Services Research
Incorporating preference heterogeneity in economic Unit, (HSRU), University of Aberdeen); Hernández, R. (HERU);
evaluation: informing “realistic medicine” (PhD) Murchie, P. (Other Applied Health Sciences, University of
Investigators: Mohan, D. (PhD Student, HERU), Scotland, Aberdeen).
G. (HERU/HSRU); Ramsay, C. (Health Services Research Unit, Source of Funding: Department of Health – National Institute
(HSRU), University of Aberdeen); Heidenreich, S. (Evidera). for Health Research (NIHR), Health Technology Assessment
Source of Funding: University of Aberdeen Development (HTA) Programme and University of Aberdeen.
Trust and Chief Scientist Office (CSO) CORE.
A randomised controlled trial: Evaluate the clinical and
Lowering Events in Non-proliferative retinopathy in cost-effectiveness of prescribing high concentration
Scotland (LENS) FLuoride toothpaste in preventing and treating dEntal
Investigators: Preiss, D. (University of Oxford); Logue, J. Caries in high-risk older adulTs (REFLeCt trial)
(University of Glasgow); Armitage, J. (University of Oxford); Investigators: Tickle, M. (University of Manchester); Boyers,
Olson, J. (NHS Grampian); Scotland, G. (HERU/HSRU); Sattar, D. (HERU); Walsh, T., Worthington, H., Glenny, A-M., Pretty, I.,
N. (University of Glasgow); Leese, G., Colhoun, H. (University of Birch, S. (University of Manchester); Clarkson, J. (University of
Dundee). Dundee).
Source of Funding: National Institute for Health Research Source of Funding: National Institute for Health Research
(NIHR) Health Technology Assessment (HTA) Programme and (NIHR) Health Technology Assessment (HTA) Programme.
Chief Scientist Office (CSO) CORE.

HERU ANNUAL REPORT 2019 29